Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Add To Watchlist

TSX:LABS - Post Discussion

Medipharm Labs Corp > American market potential

View:

Post by alleyesonme on May 01, 2024 11:38am

American market potential

Schedule 3 means cannabis now will be in the same classification as Tylenol, cough syrup, antihistamine's, etc.., prescription pharmaceutical's like the 505b2, or novel new drugs MPL's partners or clients are developing, as mentioned on the investor deck will now have a much stronger chance of being approved....the acceptance from HHS, FDA, DEA of cannabis and its compounds holding medical merit, as opposed to schedule 1, no medical merit is absolutely huge....once this is finalized, potential for deals in stores like CVS and Walgreens are possible ...looking forward to seeing regulations, research trials/ Pharmaceuticals/ OTC medical...IMO......BULLISH more than ever.